Home/Filings/4/0000880984-22-000007
4//SEC Filing

Javitt Daniel C. 4

Accession 0000880984-22-000007

CIK 0001719406other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 8:11 PM ET

Size

8.0 KB

Accession

0000880984-22-000007

Insider Transaction Report

Form 4
Period: 2022-06-03
Transactions
  • Sale

    Common Stock

    2022-06-03$0.70/sh243,596$171,10212,859,080 total(indirect: By LLC)
  • Sale

    Common Stock

    2022-06-06$0.67/sh115,657$76,94712,743,423 total(indirect: By LLC)
  • Sale

    Common Stock

    2022-06-07$0.65/sh86,459$55,86112,656,964 total(indirect: By LLC)
Footnotes (1)
  • [F1]Held by Glytech LLC of which the Reporting Person is the sole owner.

Issuer

NRX Pharmaceuticals, Inc.

CIK 0001719406

Entity typeother

Related Parties

1
  • filerCIK 0001864534

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 8:11 PM ET
Size
8.0 KB